Wrap 310, which are billed as being the world s first sunglass-style
16×9 widescreen video glasses to hit the market, have now hit retail.
Offering imagery that s equivalent to viewing a 55 � screen at a
distance of 10ft courtesy of dual high-resolution 428 x 240 24 "bit true
color LCD widescreen displays, the newly released Vuzix Wrap 310 Video
Eyewear offer a wide range of device compatibility taking in such as the
iPhone, iPods, portable DVD player, video capable mobile phones,
PCs/laptops and PMPs, and, as well as supporting 2D video also boast
compatibility with 3D video formats inclusive of Vuzix Auto-3D.
Vuzix Wrap 310 Video Eyewear Key Features:
Supports 4:3 and 16:9 display formats
Adjustable brightness, contrast and color saturation
Works with 2D and common 3D video formats including side-by-side and
anaglyph
Supports �Vuzix Auto-3D �, automatic 3D detection technology 1
NTSC and PAL compatible
Connects to all video devices with composite video
Six hours use with 2 AA alkaline batteries
Video zoom mode
Onscreen display for video display adjustment
Includes Wrap multi-connect port for optional adaptors offering expanded
compatibility
Includes Wrap mini-port connector for optional expansion accessories
Ultra-thin cabling
Detachable premium quality noise-isolating earphones
Includes 3 sizes of noise isolation inserts
Wearable over most prescription eyeglasses
Independent left and right eye focal adjustment
Nine foot visual focus " reading glasses not required
Adjustable, hypoallergenic nosepiece
Changeable lens
The Wrap 310 promises to change the game in portable video and we're
thrilled to officially deliver this product to the masses, said Vuzix
CEO, Paul Travers. The Wrap 310 also brings advanced features to the
video Eyewear category that no product has. With capabilities to add
tracking and cameras that enable augmented reality and incredible gaming
experiences; there is nothing like it on the market.
The Vuzix Wrap 310 Video Eyewear is available now and will set you back
just shy of $250.




No comments:
Post a Comment